MAG
GNMK

Millrace Asset Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Millrace Asset Group’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-264,348
Closed -$1.6M – 75
2019
Q3 		$1.6M Buy
264,348
+15,635
+6% +$97.6K 1.88% 20
2019
Q2 		$1.61M Sell
248,713
-88,309
-26% -$622K 1.67% 24
2019
Q1 		$2.39M Sell
337,022
-27,395
-8% -$180K 2.02% 14
2018
Q4 		$1.77M Buy
+364,417
New +$1.9M 1.62% 27

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millrace Asset Group's GNMK Position: Q4 2019 in Review

Millrace Asset Group sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2019, closing a stake of 264,348 shares — an estimated $1.6M sold.

Millrace Asset Group first reported a position in GNMK in Q4 2018 and held it in 4 quarters. The position peaked at $2.39M in Q1 2019. 111 funds tracked by Wall St. Rank hold GNMK as of Q4 2019.

  • Millrace Asset Group reported no remaining GenMark Diagnostics, Inc position as of Q4 2019 after selling out during the quarter.
  • Millrace Asset Group sold 264,348 GenMark Diagnostics, Inc shares in Q4 2019, an estimated $1.6M.
  • Millrace Asset Group first reported a position in GenMark Diagnostics, Inc in Q4 2018 and held it in 4 quarters.
  • Millrace Asset Group's GenMark Diagnostics, Inc position peaked at $2.39M in Q1 2019.
  • 111 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2019.

Based on Millrace Asset Group's 13F filing for Q4 2019, filed 13 Feb 2020.